PDF(Pubmed)
Abstract：
The objective of this study was to explore the key elements of Korean medicine (KM) treatment for idiopathic short stature (ISS) by analyzing the strengths, weaknesses, opportunities, and threats (SWOT). This was a qualitative study of interviews with 7 KM doctors who had at least 3 years of experience in KM treatment for ISS. Based on the content, a SWOT and a cross-SWOT analysis were conducted. A SWOT of KM treatment for ISS was derived as follows: Strengths included the additional positive health promotion effects and fewer possibilities of adverse effects. Weaknesses included insufficient long-term evidence on the effect and safety and difficulty in predicting prognosis for ISS treatment in KM. Opportunities included a growing interest in height growth in general and the need for parental involvement in children height growth. Threats included the limited use of diagnostic devices and relatively high medical costs due to non-coverage by national health insurance. This study suggests that the safety and clinical effectiveness evidence of KM treatment for height growth should be guaranteed through well-designed large-scale long-term studies. Various strategies are needed to promote the use of diagnostic and evaluation devices for ISS treatment in KM clinical settings.
摘要：
这项研究的目的是通过分析其优势来探索韩国医学（KM）治疗特发性身材矮小（ISS）的关键要素，弱点,机遇,威胁（SWOT）这是对7名KM医生的访谈的定性研究，这些医生在ISS的KM治疗方面至少有3年的经验。根据内容,进行了SWOT和交叉SWOT分析。对ISS进行KM治疗的SWOT得出如下：优势包括额外的积极健康促进作用和较少的不良反应可能性。弱点包括对KM中ISS治疗的效果和安全性以及预测预后的困难的长期证据不足。机会包括对身高增长的总体兴趣以及父母参与儿童身高增长的需求。威胁包括诊断设备的有限使用以及由于国家健康保险无法覆盖而导致的相对较高的医疗费用。这项研究表明，应通过精心设计的大规模长期研究来保证KM治疗身高增长的安全性和临床有效性证据。需要各种策略来促进在KM临床环境中使用诊断和评估设备进行ISS治疗。
